drugset / Trial / NCT01280734

Investigation of Melatonin and Zolpidem Effect on Postural Instability in Healthy Adult Subjects

NCT01280734

Phase 4 Completed 26 enrolled Neurim Pharmaceuticals Ltd.
RandomizedCrossoverDouble-blind

Summary

This is a randomised, double-blind, 3-way crossover, single dose, placebo-controlled study investigating the effect on night time awakening body sway of melatonin and zolpidem in healthy adult subjects aged of 55 to 64 years.

Timeline

Start
2011-01
Primary completion
2011-04
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 2 mg
Comparator Zolpidem Small molecule 10 mg

Indications

No indication recorded.